MESO Q4 2017 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena

MESOMesoblast Limited

$2B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$566,000-97.9% YoY

Gross Profit

-$584,000-103.2% margin

Operating Income

-$23M-4125.4% margin

Net Income

-$27M-4802.5% margin

EPS (Diluted)

$-0.51

QoQ Revenue Growth

-37.2%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$656M

Total Liabilities

$139M

Stockholders' Equity

$517M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$566,000	$27M	-97.9%
Gross Profit	-$584,000	$19M	-103.0%
Operating Income	-$23M	$36M	-164.5%
Net Income	-$27M	$48M	-156.3%